Pharmafile Logo
Pharmafocus logo
Advanced Search

Qtrilmet

Showing 1 posts of 1 posts found.

AstraZeneca’s Qtrilment scores European authorisation in type 2 diabetes

November 15, 2019
Medical Communications, Sales and Marketing AstraZeneca, EU, Europe, Qtrilmet, diabetes, pharma, type 2 diabetes

Qtrilmet (metformin hydrochloride, saxagliptin and dapagliflozin) has secured approval in Europe, its manufacturer AstraZeneca has revealed, as a therapy to …

News
The Gateway to Local Adoption Series

Latest content

Pharma sees climate disruption as growing supply-chain risk

September 11, 2026

Manchester NHS-MHRA partnership to test new technologies in real-world care

September 10, 2026

Ondine reports 40% reduction in surgical-site infections in phase 3 trial

September 9, 2026

Northern Ireland to roll out staff well-being training across health service

September 8, 2026

European consortium demonstrates continuous manufacturing platform for pharmaceutical ingredients

September 7, 2026